"La chirurgia del pancreas, appartenente all’istituto del pancreas di Verona è centro di riferimento nazionale per la diagnosi, la cura e la ricerca sulle malattie del pancreas di interesse chirurgico (adenocarcinoma, tumori cistici, tumori neuroendocrini, altri tumori rari, pancreatiti acute e croniche). Per maggiori informazioni visitare i nostri siti internet istituzionali."

During the past decade, General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital" are "Borderline Resectable Pancreatic Cancer" (1 trials) and "Pancreatic and Peripancreatic Tumors" (1 trials). Many other conditions were trialed in "General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital" in a lesser frequency.

Most popular intervention types in "General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital" are "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Intraoperative radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in General and Pancreatic Surgery Unit, Pancreas Institute, University of Verona Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".